Showing 1 - 10 of 134
Persistent link: https://www.econbiz.de/10000508255
Persistent link: https://www.econbiz.de/10011489029
Persistent link: https://www.econbiz.de/10011971571
This study aims to build on the findings from the previously mentioned studies, and seeks to provide more detailed information on the costs of the various functions and categories of expenditure involved in the establishment and operation of system for the prevention and control of emerging...
Persistent link: https://www.econbiz.de/10012556953
A growing body of evidence from economic studies shows areas where appropriate policies can generate health and other benefits at an affordable cost, sometimes reducing health expenditure and helping to redress health inequalities at the same time. The evidence is especially strong for policies...
Persistent link: https://www.econbiz.de/10012448862
Antimicrobial resistance (AMR) is a large and growing problem with the potential for enormous health and economic consequences, globally. As such, AMR has become a central issue at the top of the public health agenda of OECD countries and beyond. In this report, OECD used advanced techniques,...
Persistent link: https://www.econbiz.de/10012451043
Antimicrobial resistance (AMR) is a biological mechanism whereby a microorganism evolves over time to develop the ability to become resistant to antimicrobial therapies such as antibiotics. The drivers of and potential solutions to AMR are complex, often spanning multiple sectors. The...
Persistent link: https://www.econbiz.de/10012512188
Eswatini's fundamental policy challenge is to address the longstanding factors that have constrained growth and hindered broad-based improvements in living standards. Given the state's significant role in the economy, the build-up of macro imbalances, and slow improvements in social indicators,...
Persistent link: https://www.econbiz.de/10015372312
Persistent link: https://www.econbiz.de/10001355862
Over one million people world-wide have benefited from successful tissue and organ transplants and survival rates have dramatically improved. But transplantation has become a victim of its own success. The demand for human organs can no longer be met and deaths of persons on waiting lists have...
Persistent link: https://www.econbiz.de/10012448612